Note: Single-source report; awaiting corroboration.
On the International Space Station (ISS), Expedition 74 astronauts are investigating how pneumonia-causing bacteria damage the heart over time. Researchers use stem cell-derived heart tissues exposed to bacterial infections in space to better understand cardiovascular health and infectious disease management. The space environment intensifies bacterial severity and drug resistance, allowing scientists to observe cellular responses to infection that may be hard to detect on Earth.
Dr. Palaniappan Sethu, professor at the University of Alabama at Birmingham, explains that space exacerbates infection, enabling clearer differentiation between infected and control groups and revealing subtle factors that enhance bacterial virulence. The research focuses on Streptococcus pneumoniae, a major cause of community-acquired pneumonia responsible for millions of deaths annually. More than 25% of adults hospitalized with this pneumonia develop heart disease, and survivors face increased long-term risk.
Beyond Earth-based health, this research supports strategies for extended space missions. Dr. Carlos J. Orihuela, professor of Microbiology at the University of Alabama at Birmingham, notes the importance of understanding how space-specific factors affect disease progression to ensure astronaut health and sustainable habitation beyond Earth. The ISS provides a platform for global researchers to address complex health issues by studying disease, drug testing, and diagnostics in unique environmental conditions.